News: Momenta Pharmaceuticals Inc (MNTA.OQ)
MNTA.OQ on NASDAQ Stock Exchange Global Select Market
16.53USD
1 Aug 2013
16.53USD
1 Aug 2013
Price Change (% chg)
$-0.73 (-4.23%)
$-0.73 (-4.23%)
Prev Close
$17.26
$17.26
Open
$16.78
$16.78
Day's High
$16.95
$16.95
Day's Low
$16.48
$16.48
Volume
233,326
233,326
Avg. Vol
137,075
137,075
52-wk High
$18.02
$18.02
52-wk Low
$10.05
$10.05
Select another date:
Select another date:
- Momenta Pharmaceuticals' CEO Discusses Q2 2013 Results - Earnings Call Transcript
- Momenta Latest to Take Advantage of Teva's Patent Woes
- Should You Add Momenta to Your Portfolio?
- Rexahn's Oncology Platform Led By Its Akt-1 Inhibitor Challenges Big Pharma With Ground-Breaking Cancer Therapy
- Momenta Pharmaceuticals' Management Presents at 38th Annual dbAccess Health Care Conference (Transcript)
- The 5 Best Dividend Stocks of 2020
Press Releases
- Momenta Pharmaceuticals to Present at the Deutsche Bank 2012 dbAccess BioFEST
- U.S. Court of Appeals Denied Momenta Pharmaceuticals Petition for Rehearing En Banc in "Safe-Harbor" Case
- Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
- Momenta Pharmaceuticals Reports Third Quarter 2012 Financial Results
- A Refreshing Outlook - Consensus Reports on Keryx Biopharmaceuticals, Inc. and Momenta Pharmaceuticals, Inc.
- Momenta Pharmaceuticals Announces Date of Third Quarter 2012 Financial Results Conference Call
- Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
- Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
- Momenta to Present at the Canaccord Genuity 32nd Annual Growth Conference
- Momenta to Present at the Canaccord Genuity 32nd Annual Growth Conference

